TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulationJia Liu(China Pharmaceutical University), Hong Sun(Fujian Medical University)Cellular OncologyOctober 6, 202510.1007/s13402-025-01114-0Cited by 1SaveCiteExport RISWatch citationsRelated PapersA multicenter study of interocular symmetry of corneal biometrics in Chinese myopic patients|Scientific Reports|2021|27A multicenter study of the distribution pattern of posterior corneal astigmatism in Chinese myopic patients having corneal refractive surgery|Scientific Reports|2020|20<i>In vitro</i> models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of <scp>CRISPR</scp> perturbations|Molecular Oncology|2025|1